I said it before and I'll say it again, Gates in in training to fill George Soros's place. Another super rich AH that wants to rule the world.
Why Is Media Suppressing Info About Hydroxychloroquine's Effectiveness?
- Thread starter _CY_
- Start Date
https://sciencebasedmedicine.org/de...uine-why-randomized-controlled-trials-matter/
This is a very nice summary of how randomized controlled studied showed hydroxychloroquine does not help.
Included is a summary of how dexamethasone does.
This is a very nice summary of how randomized controlled studied showed hydroxychloroquine does not help.
Included is a summary of how dexamethasone does.
sorry but that's fake science .. very cleverly written to fool the masses
some truths thrown in like randomized trials are a higher form of evidence.
what they don't say is randomized trials can be designed to fail
and can be next to worthless
case in point .. the recovery trial in UK ..
patients were given 2400mg of HCQ in first 24 hours
2.4grams of HCQ is a toxic dose .. 1800 mg of HCQ is considered admission to hospital range in France. naturally they had to stop HCQ arm of recovery trial due to patients dying probably from toxic doses of HCQ given.
above is total bull manure as it's well known what HCQ dosage ranges are safe. after hundreds of millions of doses of HCQ given safely for last 50+ years. HCQ has a safety profile safer than aspirin and Tylenol.
if you want to talk dangerous ... look no further than Remdesivir .. only admin IV drip at costs of $3000 vs HCQ $20 .. randomized trials indicate remdesivir provide no improvements on death prevention. on randomized trial in USA for remdesivir had trial goals changed after trial started (fraud?) all it did was showed improvements in hospital stay by a few days. NO improvement for survival. what they never cover are the horrible side effect profile for remdesivir including kidney failure.
remdesivir is in an antiviral .. which means when anti viral are given is hugely important.
case in point .. it's well known tamiflu many not work if not given early.
reason is simple .. anti virals has to be given before virus has a chance to replicate and massively infect your body. for C19 infection the lungs become the breeding ground for viral replication. when someone with C19 .. shortness of breath is the danger signal to head for hospital.
HCQ/zinc/zpak or doxy .. if given when symptoms first presents .. has something like a 99% chance of success (not die) by shutting down viral replication.
now it's pointed out by Americasfrontlinedoctors ... there are two stages of C19 .. early stage is when HCQ/zinc/zpak or doxy should be given .. to prevent C19 patient from reaching second stage where so cells are infected body reacts with a cytokine storm.
when lungs are loaded up with liquids with body is cytokine storm ... antivirals do little if anything. this includes remdesevir and why it doesn't improve survival. anytime you see HCQ only given to late stage patients .. that trial is fake science designed to fail.
HCQ trials without zinc are also questionable .. without zinc .. HCQ working is now depends upon zinc levels in patient.
great .. we now have to deal with fake science ..
big pharma don't like it when a $20 treatment has a 99% success rate when given at onset of C19 symptoms. no vaccines needed ..
big pharma has been working on a vaccine for SARS for 15+ years with NO success. now we are to believe big pharma can safely develop a safe vaccine for COVID-19 in one year??? ya right .. I'd rather get C19 than take a new vaccine. especially when a treatment is available right now for $20 with a 99% success rate if given early. with a safely profile better than aspirin.
TRUMP TWEET: Many doctors and studies disagree with this! TWITTER TRENDS: The FDA is revoking its emergency use authorization of hydroxychloroquine and chloroquine for treating COVID-19 amid growing evidence that the drugs are "unlikely to be effective" in treating the coronavirus. (twitter.com)
Donald J. Trump
@realDonaldTrump
Many doctors and studies disagree with this!
Twitter Moments
@TwitterMoments
The FDA is revoking its emergency use authorization of hydroxychloroquine and chloroquine for treating COVID-19 amid growing evidence that the drugs are "unlikely to be effective" in treating the coronavirus. https://twitter.com/i/events/1272570857022320645…
7:26 AM · Aug 22, 2020
64.5K
See the latest COVID-19 information on Twitter
Donald J. Trump
@realDonaldTrump
Many doctors and studies disagree with this!
Twitter Moments
@TwitterMoments
The FDA is revoking its emergency use authorization of hydroxychloroquine and chloroquine for treating COVID-19 amid growing evidence that the drugs are "unlikely to be effective" in treating the coronavirus. https://twitter.com/i/events/1272570857022320645…
7:26 AM · Aug 22, 2020
64.5K
See the latest COVID-19 information on Twitter
The irony being, as the herd of anti-maskers grows larger, this is also a sheepish belief to follow. America is fighting over which kind of sheep to be.
The dex one is not “convincing”? Fine then add zinc. Safe and with low risk profile. But neither you nor I are primary COVID treatment people so that is moot......
E
thank you .. thank you, thank you for weighting in!
here's the actual study for HCQ effectiveness with and without zinc.
-----------
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and
azithromycin alone: outcomes in hospitalized COVID-19 patients
https://www.researchgate.net/public...ne_outcomes_in_hospitalized_COVID-19_patients
pdf link: https://www.researchgate.net/profil...utcomes-in-hospitalized-COVID-19-patients.pdf
Abstract
Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this novel infection. As a result of in vitro evidence suggesting zinc sulfate may be efficacious against COVID-19, our hospitals began using zinc sulfate as add-on therapy to hydroxychloroquine and azithromycin. We performed a retrospective observational study to compare hospital outcomes among patients who received hydroxychloroquine and azithromycin plus zinc versus hydroxychloroquine and azithromycin alone. Methods: Data was collected from electronic medical records for all patients being treated with admission dates ranging from March 2, 2020 through April 5, 2020. Initial clinical characteristics on presentation, medications given during the hospitalization, and hospital outcomes were recorded. Patients in the study were excluded if they were treated with other investigational medications. Results: The addition of zinc sulfate did not impact the length of hospitalization, duration of ventilation, or ICU duration. In univariate analyses, zinc sulfate increased the frequency of patients being discharged home, and decreased the need for ventilation, admission to the ICU, and mortality or transfer to hospice for patients who were never admitted to the ICU. After adjusting for the time at which zinc sulfate was added to our protocol, an increased frequency of being discharged home (OR 1.53, 95% CI 1.12-2.09) reduction in mortality or transfer to hospice remained significant (OR 0.449, 95% CI 0.271-0.744). Conclusion: This study provides the first in vivo evidence that zinc sulfate in combination with hydroxychloroquine may play a role in therapeutic management for COVID-19.
Similar threads
